biomakers

BIOMAKERS es Centro de Medicina Genómica de Precisión y Biotecnología especializado en Análisis genómicos, Big Data y desarrollo de Tecnología para Oncología y otras áreas terapéuticas complejas en Latinoamérica y USA . Cuenta con Laboratorios Moleculares propios integrados en Argentina, Mexico y Brasil, en donde se llevan a cabo estudios de biomarcadores asociados al diagnóstico genómico-molecular y una Oficina de Big Data & Technology en San Francisco, USA. BIOMAKERS prioriza la innovación a partir de la incorporación de nuevas tecnologías a través de su departamento de I+D, y el desarrollo de Plataformas Tecnológicas con Inteligencia Artificial, junto con el desarrollo e implementación de nuevos estudios genéticos para 17 países de Latinoamérica, habiendo construido el BIOBANCO de tumores avanzados y el Dataset para cáncer más importante y grande de Latino América. BIOMAKERS está conformada por profesionales con amplia trayectoria en el ámbito científico, médico, de investigación clínica, y de desarrollo de tecnología quienes cuentan con lun expertise único en la región y conforman el grupo más experto de LATAM en Medicina de Precisión. BIOMAKERS se compromete con la comunidad, a través de políticas de responsabilidad social empresaria (RSE). Desde su fundación ha comenzado a trazar esta trayectoria, a través de campañas de difusión y capacitación de diversos entes sociales (proveedores, clientes, comunidad en general), así como también programas específicos de estudios genéticos en la población latinoamericana.

Syapse

To achieve more precise care for every patient, we need to transform real-world evidence into insights that can directly impact care. At Syapse, that is real-world care. It’s found in the way we empower healthcare organizations to work together in active, transparent partnerships, delivering complete patient insights to answer the questions that matter and then purposefully applying it at where patients receive care – driving real impact for cancer patients and beyond.

Olema Oncology

Olema Oncology is a cancer medicines company dedicated to impacting breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a differentiated oral medicine known as a complete estrogen receptor antagonist (CERAN) initially in development for metastatic breast cancer. Our pipeline also includes OP-3136, a potent, selective oral inhibitor of the KAT6 pathway. At Olema, we are building a focused team committed to our mission with intention and clarity. Working alongside a talented, passionate group of leaders and advisors, we strive to create better medicines that aim to help patients feel better, longer. For more information, visit us at www.olema.com.

Plasmidsaurus

We sequence whole plasmids, amplicons, whole bacterial genomes, and colonies overnight, without the need for primers and minipreps. Plasmidsaurus is on a mission to accelerate new cures and promote a healthier planet by unlocking new levels of productivity in scientists using DNA tools to bring their ideas to life. The company’s DNA sequencing services are used daily by thousands of innovators, including Nobel prize winners, dynamic biotech startups, pharmaceutical companies, research labs, and DIY biohackers. Plasmidsaurus’s global network of labs operates day and night to enable world-changing discoveries. Sequence Everything!

Vaxart, Inc.

For two hundred years vaccines have been administered by intramuscular injection. Vaxart’s oral vaccine pills may change everything. Our vaccine pills act differently, by attacking invading pathogens in the places where they first enter the body: the mucosal areas, including the mouth, the nose and the gut. They are designed to trigger strong IgA and T-cell responses to repel and overwhelm the invading viral invaders. Vaxart has begun Phase II trials of its oral vaccine for Covid and for Norovirus– the only company in the world to reach this stage with a COVID-19 vaccine pill.